Next Article in Journal
Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
Next Article in Special Issue
On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer
Previous Article in Journal
Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies
Previous Article in Special Issue
Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer
 
 
Review

Article Versions Notes

Cancers 2022, 14(21), 5444; https://doi.org/10.3390/cancers14215444
Action Date Notes Link
article xml file uploaded 5 November 2022 07:20 CET Original file -
article xml uploaded. 5 November 2022 07:20 CET Update -
article pdf uploaded. 5 November 2022 07:20 CET Version of Record https://www.mdpi.com/2072-6694/14/21/5444/pdf-vor
article html file updated 5 November 2022 07:22 CET Original file -
article xml file uploaded 5 November 2022 07:54 CET Update -
article xml uploaded. 5 November 2022 07:54 CET Update -
article pdf uploaded. 5 November 2022 07:54 CET Updated version of record https://www.mdpi.com/2072-6694/14/21/5444/pdf-vor
article html file updated 5 November 2022 07:56 CET Update -
article xml file uploaded 10 November 2022 18:30 CET Update -
article xml uploaded. 10 November 2022 18:30 CET Update https://www.mdpi.com/2072-6694/14/21/5444/xml
article pdf uploaded. 10 November 2022 18:30 CET Updated version of record https://www.mdpi.com/2072-6694/14/21/5444/pdf
article html file updated 10 November 2022 18:31 CET Update -
article html file updated 28 February 2023 21:38 CET Update -
article html file updated 2 March 2023 21:10 CET Update https://www.mdpi.com/2072-6694/14/21/5444/html
Back to TopTop